United Kingdom · Biotechnology startup
United Kingdom · Cambridge Epigenetix
Cambridge Epigenetix is using epigenetics to reduce several routine & important diagnostic tests for common cancers to a simple blood draw.
Funding reportedLast round: Series D
What company datasets say Cambridge Epigenetix raised
Funding, as reported
Reported in all155.2Min the source's currency
Rounds5
Last roundSeries D
Last round dateNov 2021
Investors listed10
Funding filed with regulators
Cambridge Epigenetix filed 3 raises, $43M in all. Filings say how much was sold and to how many investors; they never name the investors.
- Jan 2026$14MUK share allotment
- Aug 2025$16MUK share allotment
- Dec 2021$13MUK share allotment
Founders and team
From Cambridge Epigenetix's own website: 5 on the team.
- Peter FromenChief Executive Officer
- Fiona StewartChief Financial Officer
- Gail MarcusChair of the Board
- Omead OstadanDirector
- Tom HulmeDirector
Biotechnology in United Kingdom
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Cambridge Epigenetix in front of investors. Or tell us what we have wrong.